logo

VOR

Vor Biopharma·NASDAQ
--
--(--)
--
--(--)

VOR fundamentals

Vor Biopharma (VOR) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -121.63 (YoY -1420.38%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-121.63
-1420.38%
Report date
Nov 13, 2025
EPS
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
-13.4-10-10-9.8-12.2-11.6-12.6-8.6-9-9.8-7.8-9-8.2-8-8.8-5.2-251.22-121.63
Forecast
-12.75-9.9-12.25-11.1971-10.2175-12.92-11.8925-7.475-8.4267-9.3556-10.0578-7.5556-8.3556-8.044-5.7143-5.2571-8.7668-3.4525
Surprise
-5.10%
-1.01%
+18.37%
+12.48%
-19.40%
+10.22%
-5.95%
-15.05%
-6.80%
-4.75%
+22.45%
-19.12%
+1.86%
+0.55%
-54.00%
+1.09%
-2765.58%
-3422.95%
Revenue
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
000000000000000000
Forecast
000000000000000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call